Skip to main
CLBT

CLBT Stock Forecast & Price Target

CLBT Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Cellebrite DI is a global leader in providing AI-powered digital investigative and intelligence solutions, specifically designed for law enforcement, defense, and intelligence agencies. Despite recent management changes, the company has consistently delivered strong free cash flow margins and is well-positioned for future growth with new products like Genesis. While near-term sales cycles are expected to lengthen, the company's loyal customer base and purpose-built platform mitigate competitive risks. With a recent pullback in stock price, shares are attractive, trading at only ~10.5x EV/CY27 FCF compared to peers at ~19-22x. Additionally, the company's high exposure to the public sector and potential technological risks should be considered, but we believe these risks are mitigated by Cellebrite's strong market position and ongoing innovation.

Bears say

Cellebrite DI is facing multiple challenges that have resulted in decreased ARR and revenue growth. These challenges include: longer sales cycles and lower expansion from Inseyets conversions, missed revenue guidance, and dependence on law enforcement and government agencies for a large portion of its revenue. Additionally, potential risks from changes in public sentiment towards law enforcement and fluctuations in foreign currency could impact the company's financial results. Despite the potential for growth from new products like Genesis, the lowered growth outlook and recent stock market corrections present a negative outlook on the company's stock.

CLBT has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cellebrite DI Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cellebrite DI Ltd (CLBT) Forecast

Analysts have given CLBT a Strong Buy based on their latest research and market trends.

According to 5 analysts, CLBT has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cellebrite DI Ltd (CLBT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.